DUBLIN--(BUSINESS WIRE)--Aug 30, 2018--The "Advanced Drug Delivery Systems - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.

The report reviews, analyzes and projects the global Advanced Drug Delivery Systems market for the period 2015-2024 in terms of value in US$ and the compound annual growth rates (CAGRs) projected from 2017 through 2024.

Pharmaceutical companies have developed numerous therapeutic compounds that can address several life threatening ailments or disorders. The traditional dosage form offers spontaneous drug liberation that leads to drug concentration variation in the circulatory system. Hence to regulate the steady effective drug levels in the blood, introduction of Advanced Drug Delivery System is essential.

Availability of the therapeutic compounds that are site specific, exhibit maximum therapeutic efficacy, capable of performing the same action in minimal dosage forms, increase in research and development protocols that aim to introduce maximum number of advanced drug delivery systems are some of the factors responsible for the growth of Advanced Drug Delivery Systems market.

Research Findings & Coverage

Global Advanced Drug Delivery Systems market is analyzed in this report with respect to carrier types, route of administration and applications Degradable Microneedle - Promising Future Injectable Drug Delivery System Electrospun Based Nanofibers - A Novel Drug Delivery System Reduction-Sensitive Polymer Nanomedicines - Future Targeted Drug Delivery Platform for Cancer Platelets Serving as a Novel Drug Carrier Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments Major companies profiled - 39 The industry guide includes the contact details for 204 companies

Product Outline

The report analyzes the market for the following carrier types of Advanced Drug Delivery Systems:

Nanoparticles Polymers Monoclonal Antibodies Others (includes Prodrugs, Microparticles etc.) Advanced Drug Delivery Systems market, in terms of Route of Administration, analyzed in this report include the following: Oral Parenteral Topical Others (includes Rectal, Nasal, Implants etc.) The study explores the market for Advanced Drug Delivery Systems applications comprises: Oncology Cardiology Neurology Pulmonary Other Applications (includes Diabetes, Ophthalmology, Gastrointestinal disorders, Urology etc.)

Key Topics Covered:

1. Introduction

2. Key Market Trends

3. Key Global Players

4. Key Business & Product Trends

5. Global Market Overview

6. North America

7. Europe

8. Asia-Pacific

9. Rest Of World

Companies Mentioned

3M Company Adare Pharmaceuticals, Inc Aesica Alkermes, Inc. Amgen Astrazeneca PLC Avadel Bayer AG Becton, Dickinson and Company Bespak Europe Ltd Capsugel, Inc. Catalent, Inc. Cipla Consort Medical PLC Crossject DelSiTech Elixir Medical Corporation European Pharma Group BV Eyepoint Pharmaceuticals, Inc. Fusion Consulting Group Genexine Gerresheimer AG HNS International, Inc. Harvard Heron Therapeutics, Inc. Hisamitsu Pharmaceutical Co., Inc. Injex UK Ltd Insulet Corporation Kempharm, Inc. Kyoto Medical Planning Co., Ltd Lupin Ltd MED TRUST Mannkind Corporation Medical International Technologies (MIT Canada) Inc. Movi SpA Mundipharma Mylan Laboratories National Medical Products, Inc. Nektar Therapeutics Novartis Novavax, Inc. Noven Pharmaceuticals, Inc. Panacea PharmaJet SHL Group Sensile Medical AG Serum Institute Skyepharma Production SAS Theraject, Inc. Tolmar Pharmaceuticals, Inc. Vaccibody Valeritas, Inc. West Pharmaceutical Services, Inc. XEL Pharmaceuticals, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/4p6qm2/advanced_drug?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180830005301/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Delivery



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/30/2018 04:38 AM/DISC: 08/30/2018 04:38 AM